Lipopolysaccharide contamination in intradermal DNA vaccination: toxic impurity or adjuvant?

J.H. van den Berg; S.G.L. Quaak; J.H. Beijnen; W.E. Hennink; G. Storm; T.N. Schumacher; J.B. Haanen; B. Nuijen

Lipopolysaccharide contamination in intradermal DNA vaccination: toxic impurity or adjuvant?

J.H. van den Berg
, S.G.L. Quaak
, J.H. Beijnen
, W.E. Hennink
, G. Storm
, T.N. Schumacher
, J.B. Haanen
, B. Nuijen

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	32-36
Number of pages	5
Journal	International Journal of Pharmaceutics
Volume	390
Issue number	1
Publication status	Published - 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Medical technology
Farmacie(FARM)
Biomedische technologie en medicijnen
Pharmacology

Cite this

@article{9938f807064048349573a536bb648955,

title = "Lipopolysaccharide contamination in intradermal DNA vaccination: toxic impurity or adjuvant?",

keywords = "Medical technology, Farmacie(FARM), Biomedische technologie en medicijnen, Pharmacology",

author = "\{van den Berg\}, J.H. and S.G.L. Quaak and J.H. Beijnen and W.E. Hennink and G. Storm and T.N. Schumacher and J.B. Haanen and B. Nuijen",

year = "2010",

language = "Undefined/Unknown",

volume = "390",

pages = "32--36",

journal = "International Journal of Pharmaceutics",

issn = "0378-5173",